🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆
Clinical Trials in Spain / NCT07484919
Recruiting Not applicable

Virtual Reality Intervention (VR-GINSO) for Reducing Aggression in Young Offenders

NCT07484919 · tracked via the Priya Life Science Spain tracker
Phase
Not applicable
Started
2025-12-15
Last updated
2026-03-20

Condition(s) studied

Aggression

Investigational drug(s) / intervention(s)

Virtual RealityActive ControlTreatment as usual

Virtual Reality: This group will receive 4 individual behavioral therapy sessions on emotion recognition, hostile attribution bias, anger management, and social problem-solving. During these sessions, participants will train specific abilities through various activities. The activities are designed as a serious game in a virtual reality setting and include: emotion identification and recognition, practicing interpreting frustrating situations without assuming hostility, anger regulation in provocative situations, and decision-making in interpersonal conflict situations. In addition, there will be one session before the program to collect baseline data and one session after the program to collect post-intervention data. A follow-up session will take place 3 months after the post-intervention assessment.

Active Control: This group will receive the same intervention as the Virtual Reality group, but in a group format (4 participants per group). The training and activities will be conducted using video or paper materials and traditional psychological techniques such as imagination. There will be 4 group behavioral therapy sessions on emotion recognition, hostile attribution bias, anger management, and social problem-solving. During these sessions, participants will train specific abilities through various activities. The activities include: emotion identification and recognition, practicing interpreting frustrating situations without assuming hostility, anger regulation in provocative situations, and decision-making in interpersonal conflict situations. In addition, there will be one session before the program to collect baseline data and one session after the program to collect post-intervention data. A follow-up session will take place 3 months after the post-intervention assessment.

Treatment as usual: Participants in this group will receive treatment as usual provided by the facility, with no additional intervention. Treatment will be delivered over the same period of time as in the other study groups. Participants will complete one baseline assessment before the study period, one post-intervention assessment, and a follow-up assessment 3 months after the post-intervention evaluation.

Study summary

The goal of this clinical trial is to see if a specific intervention program that uses virtual reality (VR) helps young people reduce aggressive behavior more than the same program without VR or their usual treatment. The study will also look at how the program affects anger, impulsivity, emotional control, and how participants understand and handle conflicts with others.

The main questions the study wants to answer are:

* Does the intervention program with VR help young people reduce aggressive behavior more than the same program without VR or just their usual treatment?
* What changes in the mind and body are linked to improvements in aggressive behavior and emotional control?

The researchers will compare three groups of young people:

* Usual treatment plus the 4-session intervention program with VR.
* Usual treatment plus the 4-session intervention program without VR.
* Usual treatment only.

Participants will:

* Attend 4 individual sessions lasting 1 to 1.5 hours, once a week.
* Take part in activities to learn how to recognize emotions, understand conflict situations, and manage anger and impulsivity.
* Complete questionnaires about aggressive behavior, anger, impulsivity, emotional control, and how they interpret conflicts.
* Have their aggressive behavior recorded through disciplinary reports at the center.
* Provide saliva samples before and after sessions to measure hormones related to stress and aggression.
* Wear a chest band that measures heart rate and a headset that records brain activity during the VR activities.

All data will be kept confidential, and the identities of participants will be protected at all times.

Eligibility

Sex
ALL
Min age
12 Years
Max age
18 Years
Healthy volunteers
No
Inclusion Criteria: * 12-18 years old at the moment of recruitment and allocation. * Minimum facility stay of 6 months since the begining of the study. * Documented records of recent aggresive behavior. Exclusion Criteria: * Neurological disorder, brain injury, or psyquiatric pathology that affects cognitive functions or advises against use of virtual reality. * Not being fluent in Spanish.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Universidad Francisco de Vitoria Pozuelo de Alarcón Cominity of Madrid Recruiting

More Universidad Francisco de Vitoria trials in Spain

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07484919 on ClinicalTrials.gov ↗ ← All trials in Spain